Medical Research News

RSS

Study examines performance of fabrics for home-made masks against the spread of COVID-19

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

19 Sep 2020

$Using AI and fractal dimension to accurately monitor ataxia$

Using AI and fractal dimension to accurately monitor ataxia

Exploiting artificial intelligence (AI) to develop tools for improving the monitoring of treatment of rare, progressive, and highly debilitating diseases such as Friedreich's (FRDA) and spinocerebellar ataxia (SCA).

19 Sep 2020

UConn researchers validate clinical feasibility of CRISPR-based platform for COVID-19 testing

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

19 Sep 2020

Stroke patients with COVID-19 have increased systemic inflammation, higher mortality risk

Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according to University of Alabama at Birmingham research led by Chen Lin, M.D., an assistant professor in the UAB Department of Neurology.

19 Sep 2020

Scientists identify new drug to prevent SARS-CoV-2 infection consequences

Scientists from the Department of Cell Biology of the University of Malaga and the Andalusian Centre for Nanomedicine and Biotechnology have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

19 Sep 2020

Confidence in COVID-19 restrictions leads to good mental health

In March 2020, Covid-19 was declared a global pandemic, and governments around the world imposed restrictions to reduce the spread of the Coronavirus.

19 Sep 2020

Discovery could help enhance the effectiveness of immunotherapy against melanoma

Researchers at the University of Bern have discovered a mechanism in the body’s own immune system which is responsible for the maturation and activation of immune cells.

19 Sep 2020

Study suggests e-cigarettes are contributing to reduce smoking prevalence

People who smoke are increasingly using e-cigarettes to try to quit smoking, a study by researchers at the University of Otago, Wellington, has found.

18 Sep 2020

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

To investigate mutations in coronaviruses, a new study by scientists at Duke University and published on the preprint server bioRxiv, used a computational methodology, adaptiPhy, which identifies extra nucleotide substitutions in certain parts of the viral genome compared to mutations that have no effect on the genome.

18 Sep 2020

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Scientists at the University of Wisconsin reveals that the genetic variants of human angiotensin 2 (ACE2) receptors can have altered recognition by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. The study is currently available on the bioRxiv* preprint server.

18 Sep 2020

Combination of two mosquito-borne viruses may be a trigger for stroke

A deadly combination of two mosquito-borne viruses may be a trigger for stroke, new research published in the The Lancet Neurology has found.

18 Sep 2020

Researchers identify new path to defeating chronic myelogenous leukemia

Researchers have identified a second path to defeating chronic myelogenous leukemia, which tends to affect older adults, even in the face of resistance to existing drugs.

18 Sep 2020

Actively speaking two languages delays the onset of mild cognitive impairment

As well as allowing us to communicate with other people, languages are the tool we use to convey our thoughts, identity, knowledge, and the way we see and understand the world.

18 Sep 2020

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

A new study published on the preprint server bioRxiv* in September 2020 reports on a Moloney murine leukemia virus (MLV) platform that produces VLPs expressing the important spike antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Sep 2020

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus.

18 Sep 2020

ACC’s initiative can help cardiologists address critical patient needs, deliver high-quality care

The American College of Cardiology's ongoing COVID-19 response initiative is welcoming support from the Boehringer Ingelheim and Eli Lilly and Company Alliance to continue providing real-time clinical guidance on COVID-19.

18 Sep 2020

Study invalidates Ebselen and other broad-spectrum SARS-CoV-2 Mpro inhibitors

Other novel compounds with Mpro inhibitory activity have also been claimed to have antiviral activity. These include ebselen, disulfiram, tideglusib, carmofur, shikonin, and PX-12. A new research paper discusses the role of these molecules as potential Mpro inhibitors in the prevention of SARS-CoV-2 infection.

18 Sep 2020

Study: 90-minute COVID-19 test has high sensitivity and specificity

A 90-minute COVID-19 test has been shown to have over 94 per cent sensitivity, and 100 per cent specificity in a new study.

18 Sep 2020

EMPAIA project aims to build a platform for AI-assisted solutions

The EMPAIA project, which is led by Charité - Universitätsmedizin Berlin, has been crowned one of the winners of the AI Innovation Competition organized by the Federal Ministry for Economic Affairs and Energy (BMWi).

18 Sep 2020

Study highlights need for scientific, pharmaceutical standards for developing live biotherapeutic products

The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".

18 Sep 2020

Medical Research News

Study examines performance of fabrics for home-made masks against the spread of COVID-19

Using AI and fractal dimension to accurately monitor ataxia

UConn researchers validate clinical feasibility of CRISPR-based platform for COVID-19 testing

Stroke patients with COVID-19 have increased systemic inflammation, higher mortality risk

Scientists identify new drug to prevent SARS-CoV-2 infection consequences

Confidence in COVID-19 restrictions leads to good mental health

Discovery could help enhance the effectiveness of immunotherapy against melanoma

Study suggests e-cigarettes are contributing to reduce smoking prevalence

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Combination of two mosquito-borne viruses may be a trigger for stroke

Researchers identify new path to defeating chronic myelogenous leukemia

Actively speaking two languages delays the onset of mild cognitive impairment

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

ACC’s initiative can help cardiologists address critical patient needs, deliver high-quality care

Study invalidates Ebselen and other broad-spectrum SARS-CoV-2 Mpro inhibitors

Study: 90-minute COVID-19 test has high sensitivity and specificity

EMPAIA project aims to build a platform for AI-assisted solutions

Study highlights need for scientific, pharmaceutical standards for developing live biotherapeutic products

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News